Nabla
PrivateLast Round
Series C
Jun 17, 2025
Total Funding Raised
$107.26M
Company Overview
Nabla Bio is a biotechnology company that develops the autoverse platform for medical and industrial applications, utilizing advanced proteins derived from extensive natural insights to facilitate complex protein function measurements for clients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nabla Comps
Public and private peers based on sector, stage, and business model.
Nabla Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2025 | ||||
| Series A | May 14, 2024 | ||||
| Seed | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 |
Nabla Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | Series C |
| DST Global | Series C |
| Khosla Ventures | Series A, Seed |
| Cantos Ventures | Seed |
| Zetta Venture Partners | Series A, Seed |
| Pillar VC | Series A, Seed |
| GRIDS Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Received coverage in Science Magazine and Endpoints News.
- Jan 1, 2026
Partnerships disclosed with AstraZeneca, Takeda, and Bristol Myers Squibb.
Nabla Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nabla's valuation, stock price, and market status.
